GOSSAMER BIO, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $29.2M | $30.2M | $138.9M |
| Jun 2022 | $17.6M | $-16.5M | $94.3M |
| Sep 2022 | $14.8M | $56.4M | $153.5M |
| Dec 2022 | $12.0M | $12.1M | $112.0M |
| Mar 2023 | $9.2M | $-28.5M | $65.2M |
| Jun 2023 | $6.4M | $-62.8M | $37.0M |
| Sep 2023 | $3.6M | $104.6M | $82.6M |
| Dec 2023 | $814.0K | $62.8M | $32.1M |
| Mar 2024 | $0 | $26.7M | $38.9M |
| Jun 2024 | $0 | $81.5M | $86.9M |
| Sep 2024 | $0 | $54.1M | $28.5M |
| Dec 2024 | $0 | $29.5M | $46.1M |
| Mar 2025 | — | $-6.3M | $29.0M |
| Jun 2025 | — | $-46.1M | $26.3M |
| Sep 2025 | — | $-82.3M | $8.9M |
| Dec 2025 | — | $-122.8M | $37.7M |
| Mar 2026 | — | $-161.5M | $41.0M |
| Jun 2026 | — | $-94.0M | $41.1M |